COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 125 filers reported holding COHERUS BIOSCIENCES INC in Q4 2016. The put-call ratio across all filers is 4.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $174,000 | +1238.5% | 18,108 | +933.0% | 0.01% | – |
| Q2 2022 | $13,000 | -92.3% | 1,753 | -86.6% | 0.00% | -100.0% |
| Q1 2022 | $169,000 | +42.0% | 13,097 | +75.6% | 0.01% | +50.0% |
| Q4 2021 | $119,000 | -51.2% | 7,458 | -57.7% | 0.00% | -50.0% |
| Q2 2021 | $244,000 | +6000.0% | 17,617 | +8752.8% | 0.01% | +700.0% |
| Q3 2019 | $4,000 | -71.4% | 199 | -68.5% | 0.00% | -75.0% |
| Q2 2019 | $14,000 | – | 631 | +4407.1% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 14 | -88.5% | 0.00% | -100.0% |
| Q3 2018 | $2,000 | -85.7% | 122 | -92.6% | 0.00% | -90.9% |
| Q4 2017 | $14,000 | -70.8% | 1,638 | -50.8% | 0.01% | -78.0% |
| Q2 2017 | $48,000 | +242.9% | 3,328 | +586.2% | 0.05% | +257.1% |
| Q4 2016 | $14,000 | -81.3% | 485 | -82.7% | 0.01% | -65.9% |
| Q3 2016 | $75,000 | – | 2,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |